Fresenius Kabi Compound α‑Ketoacid Tablets Product Leaflet

Product leaflet for Fresenius Kabi Compound α‑Ketoacid Tablets, detailing composition, dosage, indications, and safety information.


Fresenius Kabi Compound α‑Ketoacid Tablets Product Leaflet - cover page
Brand
Fresenius Kabi
Document type
Product Leaflet
Language
Chinese
Pages
4
File format
PDF
File size
163 KB
Published
01 October, 2026
Updated
01 October, 2026
MD5 checksum
4C96F333BFE1A68910C3DF69707DB394

About this manual

This leaflet provides comprehensive information on Fresenius Kabi’s Compound α‑Ketoacid Tablets, a multi‑component oral formulation used in conjunction with a low‑protein diet to manage metabolic disturbances in chronic kidney disease. It lists the active keto‑amino‑acid calcium salts, essential amino acids, and total nitrogen and calcium content per tablet.

The document outlines indications, recommended dosage (4‑8 tablets three times daily for a 70 kg adult), contraindications, precautions, drug interactions, pharmacology, and storage conditions. It also includes regulatory details such as approval number, manufacturing company, and packaging specifications. This manual is written in Chinese.

What's inside

  • Composition
  • Indications
  • Dosage and Administration
  • Contraindications
  • Adverse Reactions
  • Drug Interactions
  • Pharmacology
  • Storage
  • Packaging

Specifications

α‑Ketoisocaproic acid calcium67 mg per tablet
α‑Ketoisoleucine calcium101 mg per tablet
α‑Keto‑phenylalanine calcium68 mg per tablet
α‑Keto‑valine calcium86 mg per tablet
α‑Hydroxy‑isoleucine calcium59 mg per tablet
L‑Lysine acetate105 mg per tablet
Total nitrogen36 mg per tablet
Total calcium1.25 mmol ≈ 50 mg per tablet
Tablet weight0.63 g
Packaging100 tablets per aluminum‑plastic blister pack

Frequently asked questions

What are the contraindications for this medication?

The product should not be used in patients with hypercalcemia, amino‑acid metabolism disorders, or phenylketonuria because it contains phenylalanine.

What safety monitoring is required while taking the tablets?

Blood calcium levels should be regularly monitored, and care should be taken to avoid excessive calcium intake from other sources.

How should the product be stored?

Store the tablets below 25 °C in a dry environment.

Download PDF (163 KB)